Clinical & Diagnostic
Bayer Expands Finerenone Clinical Program for Heart Failure
Recruiting approximately 15,000 patients, MOONRAKER is expected to be one of the largest heart failure (HF) study programs to date1,2,3,4 Bayer continue...
September 01, 2023 | News
Sirnaomics' STP707 Shows Promise in Phase I Solid Tumor Study
Six cohorts, totaling 50 late-stage cancer patients, received STP707 four times monthly by intravenous infusion at escalating dosages. All cohorts demon...
September 01, 2023 | News
Agilent Receives European IVDR Certification for Companion Diagnostic Assay
PD-L1 IHC 22C3 pharmDx, Code SK006, is indicated as an aid in identifying certain cancer patients for treatment with KEYTRUDA® (pembrolizumab), Merck&r...
August 30, 2023 | News
KeraLink International Reveals Innovative Plan to Eliminate Corneal Blindness
“KeraLink International is unique in our singular focus on bringing health care providers, technology innovators, philanthropists, and investors into...
August 29, 2023 | News
EU Commission Approves Pfizer's ABRYSVO™ for Infant and Elderly RSV Protection
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for ABRYSVO™, the company’s bival...
August 25, 2023 | News
Thermo Fisher Scientific Announces Launch of IVDR Certified EXENT Solutions®
Thermo Fisher Scientific, a global leader in scientific services, announced the commercial launch of its EXENT solution after receiving IVDR certification*...
August 25, 2023 | News
Salvia BioElectronics Treats First Patient with Neuromodulation for Severe Migraine in Australia
The first patient, a 29-year-old woman from Australia who has suffered from debilitating headaches since the age of 14, experienced immediate and...
August 24, 2023 | News
Thermo Fisher's Two-Day Turnaround Chromosomal Microarray Boosts Lab Productivity
Thermo Fisher Scientific, the world leader in serving science, announced the launch of a new chromosomal microarray designed to improve cytogenetic r...
August 23, 2023 | News
Paradigm Therapeutics Acquires Breakthrough Therapy for EB Treatment
Paradigm Therapeutics Inc., a biopharmaceutical company, announced the completion of the acquisition of the worldwide rights of SD-101, a topical who...
August 23, 2023 | News
MGI Partners with NGeneBio to Advance Precision Medicine
This strategic partnership will enable the integration of NGeneBio's advanced diagnostic assays with MGI's high-throughput sequencing technology to acceler...
August 23, 2023 | News
Mammotome Unveils HydroMARK™ Plus: Innovative Breast Biopsy Site Marker
"I am excited for this innovative biopsy marker to come to market," said Radiologist Dr. Evita Singh, Director of Breast Imaging at Karmanos Cancer In...
August 22, 2023 | News
Hummingbird Bioscience to Present HMBD-001 Combo Strategy for Lung Cancer at 2023 Conference
The poster will highlight the scientific rationale for combining anti-HER3 antibody HMBD-001 with EGFR inhibition and chemotherapy to improve treatment out...
August 22, 2023 | News
Everest Medicines' Partner Calliditas Therapeutics Gets FDA Priority Review for Nefecon® in IgA Nephropathy
"We congratulate our partner Calliditas for being granted priority review by the FDA for full approval and taking a step closer to offering this first-in-d...
August 22, 2023 | Regulatory
Satio Partners with BARDA DRIVe for Patch-Based Ebola Diagnostic
This groundbreaking diagnostic will combine Satio's patch-based blood collection device with Institut Pasteur de Dakar's sensitive and rapid...
August 21, 2023 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
